Skip to main content

Advertisement

Fig. 3 | Translational Neurodegeneration

Fig. 3

From: Kallikrein-related peptidases 6 and 10 are elevated in cerebrospinal fluid of patients with Alzheimer’s disease and associated with CSF-TAU and FDG-PET

Fig. 3

Levels of CSF-KLK6 in CSF of NC and patients with AD stratified to the A/T/(N) system. Levels of CSF-KLK6 in CSF of NC and patients with AD stratified to the A/T/(N) system. KLK6 levels significantly differed between AD A+/T+/N+ and AD A+/T−/N+ (p = 0.001) or NC A−/T−/N- (p < 0.001), respectively, but not between AD A+/T−/N+ and AD A−/T−/N- (p = 0.768). AD: patients with Alzheimer’s disease, NC: cognitively normal controls, A: amyloid pathology, T: tau pathology, N: neuronal injury, A/T/(N) system [54]

Back to article page